Tesofensine
most data
The Dose Guy’s verdictSep 1, 20263 sources
Tesofensine works. It has real phase 2 weight-loss numbers behind it, and if the story stopped there it would be a strong pick. It does not stop there. A triple monoamine reuptake inhibitor runs hot: heart rate up, sleep wrecked, mood riding a chemical wave that fades. The incretins have since lapped it on both effect and tolerability. The honest niche is the person who genuinely cannot tolerate a GLP-1 and still needs pharmacological help cutting weight. For everyone else, tirzepatide or retatrutide is a better road.
What it is
A triple reuptake inhibitor that blocks the reabsorption of norepinephrine, dopamine, and serotonin, the same neurotransmitters that stimulants and some antidepressants target. It was originally developed for Parkinson’s and Alzheimer’s disease, and the weight loss that showed up in those neurological trials was consistent enough that the company pivoted to obesity.
The mechanism is brute-force appetite suppression through catecholamine signaling. Tesofensine floods the synaptic gap with norepinephrine and dopamine, which kills hunger and lifts energy. A short human study found no significant change in total 24-hour energy expenditure, so the weight loss is appetite, not furnace. The cost is the stimulant ride: your resting heart rate climbs, sleep gets harder, and the mood lift is borrowed, not free. It predates the GLP-1 agonist wave. Semaglutide, tirzepatide, and retatrutide came after and showed that appetite suppression does not require living on a stimulant.
What the research shows
Real phase 2 human data, which is unusual this deep into the weight-loss shelf. The evidence is one strong obesity trial, which carries an expression of concern, plus smaller supporting studies. The neurologic-disease meta-analysis showed only -1.8% at 0.5 mg over 14 weeks against the obesity trial’s 9.2% at the same dose, so the numbers are not all telling the same story.
Realistic protocols
Tesofensine accumulates slowly. The long elimination means tesofensine builds for weeks before reaching steady state, and effects lag well behind your first dose. Start low and give it time. The community learned early that 0.5 mg is the sweet spot for most people: enough appetite suppression to matter, not enough cardiac push to be miserable. The 1 mg trial dose printed bigger weight-loss numbers but the side effects spiked with it. Dose in the morning, always. The stimulant effect wrecks sleep if you take it later, and the long elimination means it is always somewhat in your system.
Alcohol is worth mentioning: the serotonin and dopamine load changes how drinking hits, and the mood effects can be unpredictable. Most people find it better to skip it or keep it minimal while running tesofensine.
Side effects
The stimulant package, predictable and dose-dependent:
